Protocol Ledger

NCT06520163 · Phase III · RECRUITING

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Interventional Phase III clinical trial protocol NCT06520163 sponsored by The Affiliated People's Hospital of Ningbo University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-08-01 Enrollment: 99 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06520163
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)99 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06520163
Protocol FieldVerified Registry Value
NCT IdentifierNCT06520163
Consolidated Lead SponsorThe Affiliated People's Hospital of Ningbo University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment99 participants (ESTIMATED)
Registered Start Date2024-08-01
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI